How has been the historical performance of Rel. Chemotex?

Answer:The historical performance of Rel. Chemotex shows a fluctuating trend in net sales and profitability over the years. Breakdown: In the fiscal year ending March 2025, Rel. Chemotex reported net sales of 358.60 Cr, a slight decrease from 367.19 Cr in March 2024 and 364.88 Cr in March 2023. The total operating income mirrored this trend, remaining at 358.60 Cr in March 2025. The company's total expenditure, excluding depreciation, was 326.33 Cr, down from 336.13 Cr in the previous year. Operating profit (PBDIT) for March 2025 was 42.44 Cr, showing an increase from 35.33 Cr in March 2024, although it was lower than the 40.40 Cr recorded in March 2023. Profit before tax decreased to 3.66 Cr in March 2025 from 5.63 Cr in March 2024, while profit after tax rose to 4.05 Cr from 3.21 Cr in the prior year. The company's total assets were reported at 474.36 Cr in March 2025, a slight decline from 481.03 Cr in March 2024. Total liabilities also decreased to 474.36 Cr from 481.03 Cr. Cash flow from operating activities was 10.00 Cr in March 2025, down from 17.00 Cr in March 2024, while cash flow from investing activities showed a significant outflow of 32.00 Cr. Overall, the financial metrics indicate a mixed performance with some areas of growth and others showing declines.